Serine-linked PARP1 auto-modification controls PARP inhibitor response.

Serine-linked PARP1 auto-modification controls PARP inhibitor response.

Poly(ADP-ribose) polymerase 1 (PARP1) and PARP2 are recruited and activated by DNA damage, resulting in ADP-ribosylation at numerous sites, both within PARP1 itself and in other proteins. Several PARP1 and PARP2 inhibitors are currently employed in the clinic or undergoing trials for treatment of va...

Bibliografske podrobnosti
Main Authors:	Prokhorova, E, Zobel, F, Smith, R, Zentout, S, Gibbs-Seymour, I, Schützenhofer, K, Peters, A, Groslambert, J, Zorzini, V, Agnew, T, Brognard, J, Nielsen, ML, Ahel, D, Huet, S, Suskiewicz, MJ, Ahel, I
Format:	Journal article
Jezik:	English
Izdano:	Springer Nature 2021

Podobne knjige/članki

Serine-linked PARP1 auto-modification controls PARP inhibitor response
od: Evgeniia Prokhorova, et al.
Izdano: (2021-07-01)

Progress and outlook in studying the substrate specificities of PARPs and related enzymes
od: Suskiewicz, MJ, et al.
Izdano: (2020)

Bridging of DNA breaks activates PARP2–HPF1 to modify chromatin
od: Bilokapic, S, et al.
Izdano: (2020)

PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation
od: Kar, P, et al.
Izdano: (2024)

HPF1/C4orf27 is a PARP-1-interacting protein that regulates PARP-1 ADP-ribosylation activity
od: Gibbs-Seymour, I, et al.
Izdano: (2016)

HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation
od: Suskiewicz, MJ, et al.
Izdano: (2020)

PARP, transcription and chromatin modeling
od: Posavec Marjanović, M, et al.
Izdano: (2016)

Updated protein domain annotation of the PARP protein family sheds new light on biological function
od: Suskiewicz, MJ, et al.
Izdano: (2023)

Interplay of histone marks with serine ADP-ribosylation
od: Bartlett, E, et al.
Izdano: (2018)

The Making and Breaking of Serine-ADP-Ribosylation in the DNA Damage Response
od: Kira Schützenhofer, et al.
Izdano: (2021-11-01)

The potential of PARP inhibitors in targeted cancer therapy and immunotherapy
od: Jaromir Hunia, et al.
Izdano: (2022-12-01)

Mechanistic insights into the HPF1/PARP1 complex
od: Zobel, FFH
Izdano: (2021)

The role of PARPs and APLF in DNA interstrand crosslink repair
od: Zobel, F
Izdano: (2017)

Serine ADP-ribosylation in Drosophila provides insights into the evolution of reversible ADP-ribosylation signalling
od: Pietro Fontana, et al.
Izdano: (2023-06-01)

Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease
od: Prokhorova, E, et al.
Izdano: (2021)

Serine is the major residue for ADP-ribosylation upon DNA damage
od: Palazzo, L, et al.
Izdano: (2018)

Serine ADP-Ribosylation Depends on HPF1
od: Bonfiglio, J, et al.
Izdano: (2017)

Interactions of PARP1 Inhibitors with PARP1-Nucleosome Complexes
od: Natalya Maluchenko, et al.
Izdano: (2022-10-01)

Dual function of HPF1 in the modulation of PARP1 and PARP2 activities
od: Tatyana A. Kurgina, et al.
Izdano: (2021-11-01)

Combinations of PARP inhibitors with temozolomide drive PARP1 trapping and apoptosis in Ewing’s sarcoma
od: Gill, S, et al.
Izdano: (2015)

Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells
od: Paulina Gil-Kulik, et al.
Izdano: (2020-05-01)

Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential
od: Rack, JGM, et al.
Izdano: (2020)

HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones
od: Fa-Hui Sun, et al.
Izdano: (2021-02-01)

Serine is the major residue for ADP-ribosylation upon DNA damage
od: Luca Palazzo, et al.
Izdano: (2018-02-01)

Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry
od: Isabelle Maxim, et al.
Izdano: (2010-04-01)

ADP-ribosyltransferase PARP11 suppresses Zika virus in synergy with PARP12
od: Lili Li, et al.
Izdano: (2021-06-01)

Differential regulation of breast cancer bone metastasis by PARP1 and PARP2
od: Hao Zuo, et al.
Izdano: (2020-03-01)

PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels
od: Erbel C, et al.
Izdano: (2011-08-01)

PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib
od: Xia Ding, et al.
Izdano: (2022-07-01)

The contribution of PARP1, PARP2 and poly(ADP-ribosyl)ation to base excision repair in the nucleosomal context
od: M. M. Kutuzov, et al.
Izdano: (2021-03-01)

Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
od: Hyoung Kim, et al.
Izdano: (2020-07-01)

Dual Inhibitors of PARPs and ROCKs
od: Albert A. Antolín, et al.
Izdano: (2018-10-01)

Advances and perspectives of PARP inhibitors
od: Ming Yi, et al.
Izdano: (2019-11-01)

KAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer
od: Zhiyan Zhan, et al.
Izdano: (2024-09-01)

Revealing the selective mechanisms of inhibitors to PARP-1 and PARP-2 via multiple computational methods
od: Hongye Hu, et al.
Izdano: (2020-05-01)

A PARP1-related prognostic signature constructing and PARP-1 inhibitors screening for glioma
od: Hui Li, et al.
Izdano: (2022-08-01)

Virtual screening for plant PARP inhibitors – what can be learned from human PARP inhibitors?
od: Heym Peter-Paul, et al.
Izdano: (2012-05-01)

HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer
od: Hanlin Ma, et al.
Izdano: (2022-03-01)

The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency
od: Marco Gatti, et al.
Izdano: (2020-08-01)

DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on protein substrates
od: Zhu, K, et al.
Izdano: (2022)